We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SIG market cap is 4.26B. The company's latest EPS is AUD 0.0028 and P/E is 932.14.
| Year End 31 January 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 3.24B | 3.4B | 3.45B | 3.66B | 3.32B |
| Operating Income | -1.92M | 10.65M | 3.96M | 19.27M | 23.2M |
| Net Income | -12.33M | 43.53M | -7.24M | 1.81M | 4.51M |
| Year End 31 January 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 1.21B | 1.19B | 1.25B | 1.17B | 1.38B |
| Total Liabilities | 735.33M | 670.71M | 759.5M | 696.31M | 505.3M |
| Total Equity | 476.74M | 514.36M | 488.78M | 477.77M | 872.61M |
| Year End 31 January 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 200.63M | -13.13M | -46.28M | 142.74M | 41.97M |
| Investing | -68.44M | 124.36M | -16.59M | -28.6M | 5.73M |
| Financing | -100.57M | -265.71M | 128.89M | -116.94M | 295.83M |
| Market Cap | 4.26B |
| Price to Earnings Ratio | 932.14 |
| Price to Sales Ratio | 1.28 |
| Price to Cash Ratio | 11.95 |
| Price to Book Ratio | 4.88 |
| Dividend Yield | - |
| Shares Outstanding | 1.63B |
| Average Volume (1 week) | 9.23M |
| Average Volume (1 Month) | 7.93M |
| 52 Week Change | 169.07% |
| 52 Week High | 3.01 |
| 52 Week Low | 0.91 |
| Spread (Intraday) | 0.03 (1.14%) |
| Company Name | Sigma Healthcare Limited |
| Address |
3 myer place melbourne, victoria 3178 |
| Website | https://www.sigmahealthcare.com.au |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
